.webp)
HBSE Class 12 Biology Previous Year Question Paper: Haryana Board of School Education (HBSE) has released its updated date sheet for students of the 2023-2024 batch, who are the aspirants of the HBSE Board Exam 2024. According to the date sheet, the Class 12 Biology exam will be conducted on April 1, 2024, from 12:30 PM to 3:30 PM. Since the exam is just two months away, students must be entering their last phase of preparation. During the process, they might need the previous year's question papers to enhance practise and coverage of the syllabus. Hence, we have brought to you the Haryana board last year's question paper and previous year question papers class 12 with solutions.
HBSE 12th Biology Previous Year Question Papers with Solutions - Download PDF
Links to HBSE Class 12 Biology previous year's question papers with solutions have been provided in the table below. Here, HBSE Class 12 question papers for 2023 and 2022 have been attached. The board has provided four sets of question papers on each subject for better preparation.
| Haryana Board 12th Biology Previous Year Question Papers with Solutions |
Haryana Board Class 12 Biology Marking Scheme (2023 - 2024)
The marking scheme for HBSE Haryana Board Class 12 Biology 2024 has been provided in the table below. With the help of this marking scheme, students can prepare a preparation strategy for the exam.
| Type of Question | No. of Questions | Total Marks |
| MCQ Questions | 18 | 18 x 1 = 18 |
| Very Short Answer Type | 7 | 7 x 2 = 14 |
| Short Answer Type | 5 | 5 x 3 = 15 |
| Case-Based Questions | 2 | 2 x 4 = 8 |
| Long Answer Type | 3 | 3 x 5 = 15 |
Why should one solve HBSE 12th Biology Previous Year’s Question Papers?
One should solve HBSE 12th Biology Previous Year’s Question Papers because of the aforementioned reasons:
- Solving previous year's question papers increases the accuracy
- Assists students in preparing time management strategy
- It boosts the confidence of students
- The more you practise, the better your performance gets
Also Read:
Comments
All Comments (0)
Join the conversation